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Abstract
Background Semisynthetic collagen matrices are promising
duraplasty grafts with low risk of cerebrospinal fluid (CSF)
fistulas, good tissue integration and minor foreign body
reaction. The present study investigates the efficacy and
biocompatibility of a novel semisynthetic bilayered colla-
gen matrix (BCM, B. Braun Aesculap) as dural onlay graft
for duraplasty.
Methods Thirty-four pigs underwent osteoclastic trepanation,
excision of the dura, and placement of a cortical defect,
followed by duraplasty using BCM, Suturable DuraGen™
(Integra Neuroscience), or periosteum. CSF tightness and
intraoperativehandlingofthegraftswereevaluated.Pigswere
sacrificed after 1 and 6 months for histological analysis.
Findings BCM and DuraGen™ showed superior handling
than periosteum with a trend for better adhesion to dura and
CSF tightness for BCM. Periosteum, which was sutured
unlike the synthetic grafts, had the highest intraoperative
CSF tightness. Duraplasty time with periosteum was
significantly higher (14.4±2.7 min) compared with BCM
(2.8±0.8 min) or DuraGen™ (3.0±0.5 min). Tissue
integration by fibroblast infiltration was observed after 1
month for all devices. More adhesions between graft and
cortex were observed with DuraGen™ compared with
BCM and periosteum. No relevant adhesions between
leptomeninges and BCM were observed and all devices
showed comparable lymphocytic reaction of the brain. All
devices were completely integrated after 6 months. BCM
and DuraGen™ showed a trend for an enhanced lympho-
cytic reaction of the brain parenchyma compared with
periosteum. Implant rejection was not observed.
Conclusion Semisythetic collagen matrices are an attractive
alternative in duraplasty due to their easy handling, lower
surgical time, and high biocompatibility.
Keywords Collagen matrix.Dural substitute.Dural defect
repair.Duraplasty.Cerebrospinal fluid leak.BCM.
DuraGen
Introduction
Closure of dural defects is a necessity after neurosurgical
procedures to prevent cerebrospinal fluid (CSF) leakage
Parts of this study were presented at the 61st Annual Meeting of the
German Society of Neurosurgery (DGNC) in 2010
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DOI 10.1007/s00701-011-1059-5and to reduce the risk of perioperative infections [2, 12, 16,
18]. In several surgical settings primary closure is techni-
cally impossible, e.g. due to coagulation-induced shrinkage
or retraction of dura, surgical excision of dura (resection of
meningiomas), or dural injury after trauma and therefore
reconstruction of the dural defect using a substitute is
required. Reconstruction with endogenous material is most
common. However, harvesting of periosteum or fascia lata
may require extended surgical approach, additional inci-
sions and time intensive suturing.
Numerous dura substitutes are currently commercially
available. Among these dura substitutes, onlay grafts of
semisynthetic collagen matrices appear promising, since
they are thought to provide a matrix for ingrowth and
subsequent replacement by endogenous connective tissue,
while continuously presenting a mechanical barrier [7, 11].
Previous studies using DuraGen™ (Integra Neuroscience)
showed that dura onlay grafts may be superior to other
synthetic devices for duraplasty since they (1) do not
require labour-intensive suturing, (2) allow dura reconstruc-
tion with sufficient tightness to avoid perioperative CSF
fistulas effectively, and (3) cause no major reaction of the
surrounding tissue [4, 11, 16, 18].
A novel semisynthetic, two-component collagen patch
(bilayered collagen matrix, referred to as BCM, B. Braun
Aesculap) has been designed as a suturable dural onlay graft.
BCM consists of a non-cross-linked collagen sponge layer
(manufactured from bovine split hide) and a watertight non-
cross-linked collagen membrane based on lyophilized bovine
pericardium (Lyoplant™, B. Braun Aesculap). Safety and
efficacy of Lyoplant™ as a water tight dural substitute in a
clinical trial has been reported [9]. Lyoplant™,l i k eo t h e r
collagen-based dural substitutes, has to be sutured to the
dura. In contrast, BCM adheres to the dura without sutures
due to its fine pore structure of the collagen sponge allowing
capillary forces to act between the graft and the wet tissue,
holding the graft in place. In addition, the pericardium layer
within BCM provides a durable mechanical barrier and a
watertight closure of the defect, while still allowing suturing.
The aim of the present study was to investigate the safety
and efficacy of BCM in a porcine model. Sutured
autologous periosteum and DuraGen™ used as onlay graft
served as control materials. Periosteum sutured into the
dural defect is used for duraplasty most frequently.
DuraGen™ is one of the most widely used and best studied
semisynthetic grafts for dural repair in clinical use.
In contrast to previous animal studies for dural repair [1,
5, 7, 8, 10, 13–15, 17–19], in the present study, a dural
defect and a cortical lesion were created to study the
adhesion of devices to the dura, their subsequent tissue
integration, and potential adhesion and scar formation with
the underlying lesioned cortex. Properties of the dural
substitutes regarding intraoperative handling and workabil-
ity, initial watertightness of the dural reconstruction during
surgery, biocompatabiliy, tissue integration and formation of
adhesion to the intact or lesioned cortex were analysed at 1
and 6 months after the surgery.
Materials and methods
Large animal model
All procedures were performed according to the animal care
and use guidelines of the University of Pécs, Hungary
under protocol number 1301-7/1999 approved by the Ethics
Committee of the University of Pécs. Female Duroc pigs
were used. Pigs were allowed to adapt for at least a week
prior to surgery and were given pig feed and water ad
libidum until the day of surgery. Pigs were monitored daily
for general and implantation site related adverse events.
Surgical procedure
Pigs (mean weight 16.06 kg; range 12–27 kg) were
anaesthetized (125 mg of ketamine hydrochloride) after
premedication with a cocktail of azaperonum (160 mg),
ketamine (125 mg), diazepam (10 mg) and atropine
sulphate (1 mg). Endotracheal intubation was followed by
maintenance anaesthesia with 0.5% (v/v) halothane.
Animals were transferred to the prone position. After
disinfection, a midline incision of the scalp was made
and the periosteum was exposed. In animals selected for
dural reconstruction with periosteum, a 2×2-cm sheet of
periosteum was harvested and kept in a humidified
chamber. A 4-mm drill hole was made in the right frontal
region and an intracranial pressure probe (Codman ICP
Monitoring System, Codman, Le Locle, Switzerland) was
implanted into the right frontal white matter (Fig. 1). An
osteoclastic craniotomy (2.5×2 cm) was performed in the
left parietal region and a dural defect (1.5×1 cm) was created
using surgical microscissors. A cortical defect (2–3m m
diameter) was made using mild suction (Fig. 1). Haemostasis
was achieved where needed using Sangustop™ (B. Braun
Aesculap, Tuttlingen, Germany). All foreign materials were
removed before dural reconstruction. The galea was closed
using Safil™ USP 2/0 (B. Braun Aesculap) and skin closure
was done using Dafilon™ USP 2/0 (B. Braun Aesculap).
Questionnaires evaluating workability, cutting behaviour,
stiffness/flexibility, stability in a wet environment, water-
tightness and adhesion to dura were completed immediately
after wound closure for each procedure. The following
scoring was used: 1=very good, 2=good, 3=acceptable, 4=
poor, 5=not acceptable. Furthermore stickiness to instru-
ments and gloves were evaluated as: 1=without any
problem, 2=acceptable, 3=not acceptable.
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For dural reconstruction with endogenous periosteum, the
periosteal sheet was sutured into the defect using Vicryl™
USP 4/0 (Ethicon, Norderstedt, Germany). For reconstruc-
tion using BCM (B. Braun Aesculap, Tuttlingen, Germany)
or Suturable DuraGen™ (referred to as DuraGen™;I n t e g r a
Neurosciences, Plainsboro, NJ, USA), appropriate patches of
the implant were cut, hydrated with physiological saline and
placed onto the dural defect with an overlap of 5 mm at the
edges according to the manufacturers instructions (Fig. 1).
CSF tightness
To test graft adhesion and watertightness of the duraplasty,
animals were positioned head down and a Valsalva
manoeuvre was performed over 30 s. Intracranial pressure
(ICP) was monitored continuously, and the ICP at which a
CSF leak occurred was registered.
Specimens and histology
Animals were sacrificed at weeks 4 and 24 postoperatively
following premedication as described above. Animals were
anaesthesized and the left carotid artery was canulated and
the right atrium was opened. Brain tissue was perfused with
500 ml physiological saline, followed by 500 ml neutral
buffered 4% paraformaldehyde solution. The scalp was
removed and the craniotomy site was exposed. Four weeks
post-surgery, the osteoclastic defect showing varying
degrees of ossification from the edges and a central soft
tissue scar was identified in all animals. The defect was
Fig. 1 Surgical procedure. a
Semisynthetic collagen matrices
BCM (i) and DuraGen™ (ii) are
shown. b illustrates the experi-
mental approach: after creation
of the osteoclastic defect, a dural
defect and cortical lesion were
created. After haemostasis, the
dural defect was closed using an
onlay graft (i). The intracranial
pressure was monitored ((ii). c
shows dural defects closed with
periosteum (i), BCM (ii), and
DuraGen™ (iii)
Acta Neurochir (2011) 153:2241–2250 2243exposed by extending the craniotomy to 3×4 cm and
histological specimens were taken as whole-tissue blocks
containing brain parenchyma, meninges and duraplasty.
Ossification closed the cranial defect entirely after 24 weeks
in all animals. Craniotomy (3×4 cm) was performed with
an oscillating osteotome (B. Braun Aesculap) and speci-
mens were collected as whole-tissue blocks of the skull
with adherent dura and duroplasty, meninges, and brain
parenchyma. The specimens were fixed in 4% formalde-
hyde for at least 7 days. The fixed tissues were cut at the
level of the parenchymal defect and embedded in paraffin;
either in conjunction with overlaying dura or separately,
depending on adhesions. In the group examined at 6
months after surgery brain parenchyma, dura and dura-
graft were partially removed from the mineralized
craniotomy defect and embedded together with the
cranial bone after decalcification using new decalc
(Medite Medizintechnik, Burgdorf, Germany). Embedded
tissues were sectioned (1-3 μm) and stained with
haematoxylin and eosin for histology. Other sections
were stained for connective tissue (elastica-van Gieson
stain), basal membrane (silver reaction according to
Gomori) and carbohydrates (periodic acid-Schiff stain).
The stained slides were analyzed for (1) adhesions
between the device and the leptomeninges or the brain
tissue, (2) cellular reactions in the device, (3) cellular
reactions in the brain tissue, especially in the brain lesion
and (4) the integration of the device. The following scoring
scale was used for evaluations:
Histological adhesion score for meningeal structures (a)
and cortex (b): 0=no adhesions detectable, 1=adhesions
between device and (a) leptomeninges or (b) cortex, 2=
adhesions with fibroblast reaction and fibrosis in (a)
leptomeninges or (b) cortex.
Macrosopical adhesion score (6 months time point only);
quantificationoftheadherencebetweendeviceandcortex:0=
no adherence, 1=lose adherence, 2=considerable adherence.
Cellular reaction in the device: 0=no cellular infiltrates
(i.e. lymphocytes), 1=sparse lymphocytic infiltrates, 2=
considerable lymphocytic infiltrates, 3=foreign body reac-
tion/suture granuloma.
Cellular reaction in the cortical lesion below the device:
0=no cellular infiltrates (i.e. lymphocytes), 1=sparse
lymphocytic infiltrates, 2=considerable lymphocytic infil-
trates, 3=fibroblastic reaction in the brain tissue.
Integration of the device: 0=no integration, 1=ingress of
fibroblasts into the device, 2=only parts of the device
remaining detectable, 3=complete integration.
Statistical analysis
A composite primary endpoint analysis was performed
(cf. Fig. 5). The variable used for the analysis of this study
was derived by establishing a rank order of the experi-
mental animals using a hierarchical composite outcome
score. Statistical evaluation was done using standard non-
parametric Wilcoxon statistics on the rankings. This
approach is an extension of the methods described by
Follmann et al. [6] and by Bjorling et al. [3], respectively.
For the secondary endpoints, namely dura closure time
and CSF tightness, p values were computed using
unpaired Wilcoxon tests with a 95% confidence interval.
A p value<0.05 was considered statistically significant.
Results
Animals were assigned to three groups: duraplasty with
periosteum (n=11), DuraGen™ (n=10) and BCM (n=13).
Intraoperative handling of dural substitutes and water tight
dura reconstruction
Table 1 and Fig. 2 summarize the results of the question-
naires completed after wound closure to evaluate device
handling. Results for both onlay grafts were similar, with a
trend for better adhesion to dura and higher CSF tightness
for BCM. Workability of the onlay grafts was better
Autologous periosteum BCM DuraGen™
n=11 n=13 n=10
Mean score
a (range) Mean score
a (range) Mean score
a (range)
Workability 3.1 (3–4) 2.1 (2–3) 2.0
Cutting behavior 2.6 (2–3) 1.8 (1–2) 2.0
Flexibility 2.1 (2–3) 2.4 (1–4) 2.2 (2–3)
Handling in wet environment 2.0 2.1 (2–3) 2.0
Watertightness 1.2 (1–4) 2.2 (1–4) 2.5 (1–5)
Adhesion to dura - 2.1 (1–3) 2.6 (1–4)
Overall evaluation 3.0 (2–4) 2.3 (2–4) 2.8 (2–5)
Table 1 Intraoperative handling
of graft and implants: the
parameters evaluated after the
surgical procedures. Scores of 1
(very good), 2 (good), 3
(acceptable), 4 (poor), 5 (not
acceptable) were given for each
category by two surgeons
immediately following the
implantation. Scores are detailed
in “Materials and methods”
2244 Acta Neurochir (2011) 153:2241–2250compared with periosteum. However, periosteum yielded
higher watertightness. This is supported by the CSF
tightness measurements, which revealed CSF tightness at
higher ICPs for duraplasty with periosteum compared with
BCM (12.3±6.1 vs 7.7±4.0 mmHg, p=0.098) and signif-
icantly higher compared with DuraGen™ (5.5±4.6 mmHg,
p=0.02). No significant differences between the two
semisynthetic products were found (p=0.34). The time
required for duraplasty with periosteum was significantly
higher (14.4±2.7 min) compared with BCM (2.8±0.8 min)
or DuraGen™ (3.0±0.5 min).
Postoperative course and adverse events
In the periosteum group, one animal died intraoperatively
from anaesthesiological complications post duraplasty
and two animals died on days 4 and 10, but autopsy
revealed no implantation-site-related cause of death. In
the DuraGen™ group, one, two and one animal died on
postoperative days 11, 12 and 25, respectively. Subgaleal
abscesses were found in animals that died on days 11 and
12 during autopsy; for the other animal, no abnormalities
at the implantation site were found. All other animals
experienced a regular gain of size and weight at 4 weeks
(mean of 11.8 kg; range 16–41 kg) and 24 weeks (mean
of 69.6 kg; range 79–91 kg) and showed no signs of
systemic or local incompatibility. Clinically apparent
meningitis was not observed.
Macroscopic observations
At 4 weeks post-implantion
Animals from periosteum (n=4), DuraGen™ (n=3), and
BCM (n=8) groups were sacrificed at 4 weeks postopera-
tively. The osteoclastic defects with beginning osseous
consolidation were visible in all groups and showed no
differences between groups. Subcutaneous abscesses were
found in periosteum and BCM groups (n=1 in each), an
abscess in the osteoclastic defect was observed in the BCM
group (n=1). CSF fistulas or seromas or signs of intracranial
infection were not detected in any of the groups.
At 24 weeks post-implantation
A n i m a l sf r o mp e r i o s t e u m( n=4), DuraGen™ (n=3) and
BCM (n=5) groups were sacrificed at 24 weeks postopera-
*      p<0.05  
***  p<0.001 
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Fig. 2 Intraoperative handling, CSF tightness, time for duraplasty. a
Scores evaluated after surgical procedures (see “Materials and
methods”). b CSF tightness was similar between the devices with
best CSF tightness of periosteum. c Time required for closure of the
dura mater was significantly lower with BCM and DuraGen™
compared with periosteum
Acta Neurochir (2011) 153:2241–2250 2245tively. At this time point, reossification had closed the defects
in the former osteoclastic craniotomy area in all animals.
CSF fistulas, abscesses, infections, seromas or signs of
intracranial infection were not evident in any of the animals.
In the BCM group, one of five specimens (20%) showed no
adhesion, while soft or considerable adhesion of device to the
cortex was detected in one of five (20%) and three of five
(60%), respectively. In the DuraGen™ group, two of three
specimens (66.6%) showed no adhesion, while one of three
(33.3%) showed soft adhesion between device and the
cortex. In the periosteum group, considerable adherence
(75%) and soft adhesion (25%) between the graft and the
cortex was observed (Table 3, Fig. 3).
Histological analysis of implant integration
At 4 weeks post-implantion
In the BCM group, seven of eight specimens (87.5%)
showed no adhesions of the graft to the leptomeninges,
whereas the leptomeninges were adherent to the device in
one of eight (12.5%). Cortical lesion was adherent to the
graft in six of eight specimens (75%), while one of eight
(12.5%) showed no adhesion, and scar formation was
observed in one of eight (12.5%). Lymphocytic infiltration
of the graft was absent in two of eight (25%) and isolated
lymphocytic infiltration present in three of eight (37.5%). In
two of eight (25%) there was massive lymphocytic
infiltration, and a granuloma was observed in one of eight
(12.5%), most likely due to intraoperative contamination.
Isolated lymphocytic infiltration of the cortex were ob-
served in five of eight specimens (62.5%), but it was
massive in two of eight (25%) of specimens. One of eight
(12.5%) specimens showed ingrowth of connective tissue
into the cortex. Advanced integration of the graft into the
dura with little acellular collagen remaining was found in
seven of eight (87.5%) specimens, but one of eight (12.5%)
showed a complete integration (Table 2, Fig. 4).
In the DuraGen™ group, no adhesions between lep-
tomeninges and the graft were detected. However, scar
formation between the graft and the lesioned cortex was
observed in all three animals. In one of three specimens
(33.3%) isolated lymphocytic infiltration of the graft was
observed, in one of three (33.3%) it was massive. One
specimen showed suture granuloma (inaccurately placed
subcutaneous suture). In two of three (66.7%), isolated
lymphocytic infiltration of the cortex was observed; one of
three (33.3%) showed ingrowth of connective tissue. All
specimens showed nearly complete integration of the
device into the dura (Table 2, Fig. 4).
In the periosteum group, no adhesions between device
and leptomeninges were visible in three of four specimens
(75%); the leptomeninges were adherent to the device in
one of four (25%). In two of four (50%), the cortical lesion
was adherent to the device; in one of four, (25%) scar
formation was observed; in one of four (25%), there was no
Fig. 3 Histological and macro-
scopic analysis at 6 months
postoperatively. Skull was care-
fully separated from the speci-
mens before embedding. During
this procedure the adhesion was
scored (compare results section)
2246 Acta Neurochir (2011) 153:2241–2250adhesion between graft and cortex. As expected, suture
granulomas were observed in all samples. In three of four
(75%), isolated lymphocytic infiltration of the cortex was
found. In one of four (25%), a massive lymphocytic
infiltration of the cortex was found. All samples showed a
complete integration into the dura (Table 2, Fig. 4).
At 24 weeks post-implantion
All cranial defects were completely mineralized. Histolog-
ically, the implants were not distinguishable in any case due
to their complete integration into the scar tissue; therefore
only the lymphocytic reaction of the brain parenchyma was
analysed histologically. Lymphocytic infiltration was
isolated in two of four specimens (50%) and ingrowth
of connective tissue was observed in two of four (50%)
in BCM group. In one specimen of BCM, the cortical
lesion could not be clearly identified; this specimen was
therefore not evaluated histologically. In the DuraGen™
group, isolated lymphocytic infiltration was found in two
of three specimens (66.6%), ingrowth of connective
tissue was found in one of three specimens (33.3%).
Significant lymphocytic reaction was not detected in the
periosteum group (Table 3).
Stastistical evaluation of the primary endpoints
A rank order was defined using a composite endpoint
constructed from the histological assessment, survival, tight
pressure, dura closure time, and handling characteristics.
The ranks were analysed by unpaired Wilcoxon tests, and
non-parametric 95% confidence intervals were computed. On
a rank-range scale of 0–100, BCM was superior to Dura-
Gen™ by 37.9 points with a 95% confidence interval of the
difference of 15.2–57.6 (p=0.0025), whereas compared
with periosteum no significant difference was computed
(p=0.28). The 95%confidence interval of the difference
was −12 to 42. Finally, no significant difference wasfound
between DuraGen™ and periosteum, indicated by a 95%
confidence interval of the difference −52 to 9 (Fig. 5).
Discussion
The present study investigates efficacy and safety of
duraplasty with a novel bilayered semisynthetic collagen
matrix (BCM, B.Braun Aesculap). In particular, duraplasty
with BCM, DuraGen™ (Integra Neurosciences), and
periosteum was compared.
A dura substitute should be easy to handle, not require to
extend the surgical intervention, allow reconstruction with
high watertightness, be biologically inert, resistant to
disintegration while fully integrating into host dura, induce
no adhesion between cortex and the dura or dura substitute,
induce no adverse local or systemic reaction (immunolog-
ical, toxic, prion infection) with high biocompatibility.
Semisynthetic collagen matrices derived from animal
sources meet these conditions [2, 5, 11, 12, 16, 18].
Our results show both DuraGen™ and BCM to be
superior than periosteum in handling and time required for
duraplasty, while sutured periosteum was better in provid-
ing intraoperative watertightness. Postoperative infections
and deaths were observed in the periosteum and Dura-
Gen™ groups but not in the BCM group. Four weeks post-
implantation subcutaneous abscesses were found in one
animal each from the periosteum and the BCM group. One
animal of the BCM group showed an abscess within the
osteoclastic defect. Interestingly, infection was limited only
to the extracranial space and did not traverse the device.
None of the animals showed intracranial infection. Due to
the small number of animals in our study, extra- and
intracranial infections cannot be correlated with the type of
device.
Clinical studies using semisynthetic collagen matrix
DuraGen™ for duraplasty showed no increased risk of
infection [11, 12, 16, 18]. It is therefore likely that the
infections observed in the present study may be related to
the difficulty of maintaining an aseptic environment of the
surgical wounds in our porcine model. Future studies will
be needed to show whether the bilayered BCM with a
mechanically durable percardial layer is a better barrier
against bacterial infections.
No CSF fistulas were detected, either clinically or during
specimen collection. Taken together, these obervations indi-
cate that both semisynthetic collagen matrices (DuraGen™,
BCM) provide sufficient barrier, despite lower intraoperative
Table 2 Histological evaluation: the scores collected from the
specimens obtained after 1 month
Autologous graft DuraGen™ BCM
mean±SDM mean±SDM mean±SDM
Adhesion of graft to leptomeningeal surface
1 month 0.25±0.50 0.00±0.00 0.25±0.46
Adhesion of graft to cortical defect
1 month 1.00±0.82 2.00±0.00 1.00±0.53
Cellular reactions in the device
1 month 3.00±0.00
a 2.00±1.00 1.25±1.04
Cellular reactions in the brain tissue
1 month 1.25±0.50 1.67±1.15 1.50±0.76
6 months 0.00±0.00 1.67±1.15 2.00±1.15
Integration of device
1 month 3.00±0.00 3.00±0.00 2.13±0.35
aForeign body reaction to suture material in all cases
Acta Neurochir (2011) 153:2241–2250 2247Adhesion of graft to CNS tissue Autologous graft DuraGen™ BCM
mean±SDM mean±SDM mean±SDM
6 months 1.75±0.50 0.33±0.58 1.4±0.89
Table 3 Macroscopic findings:
the macroscopic adhesion scores
collected from the specimens
obtained after 6 months
Fig. 4 Histological analysis at
1 month postoperatively. a His-
tology of an animal randomized
to duraplasty with BCM.
Neither the cortical lesion (CL)
nor the leptomeninges were
markedly adherent to the device
(D), which showed isolated
lymphocytic infiltration. b
Duraplasty with DuraGen™
(i, ii) or periosteum (iii, iv)
2248 Acta Neurochir (2011) 153:2241–2250CSF tightness compared with sutured periosteum. These
results are supported by clinical studies reporting 0% in
79 patients [12] and 0.4% in 439 patients [16]o fC S F
fistulas after duraplasty with DuraGen™.F u r t h e r m o r e ,
Barth and co-workers [2] demonstrated that, in 53 patients
with supratentorial craniotomies who received an adaptive
dura closure only, the risk of dura closure-related compli-
cations was not significantly higher compared with
patients receiving watertight duraplasty. This shows that
watertight suturing of the onlay grafts provides no
additional advantage if the graft was placed on the dura
with sufficient overlap, but could be helpful in cases where
the remaining dural tissue does not allow sufficient
o v e r l a po fg r a f ta n dd u r ao rw h e r et e n s i o no nt h ed u r ao r
the graft may prevent safe graft positioning.
For clinical use, caution is necessary when onlay grafts are
used in patients with hydrocephalus or for the closure of
infratentorial or basal defects. In this case, the lower CSF
tightness observed with the onlay grafts may play a more
significant role. Whether the risk of CSF fistulas in high-risk
patients can be avoided by using suturing of the grafts, which is
possible with BCM and DuraGen™, remains to be determined.
Histological analysis showed tissue integration by
fibroblast invasion into all devices after 4 weeks. Implant
rejection was not observed in any group. Both DuraGen™
and BCM showed remaining structures of the implant; most
notably of the compact layer of BCM derived from the
pericardium facing the subcutaneous tissue. Periosteum was
integrated and was identifiable only at overlapping edges of
the implant and dural defect as a slightly different
connective tissue structure of the connective tissue layers.
Although lymphocytic reaction of the implants was lowest
in the periosteum group, foreign body reaction to suture
material was observed consistently. Lymphocytic infiltration
tended to be lower in BCM compared with DuraGen™.
Cortical reaction at the lesion site showed a fibrous reaction
with DuraGen™ (one of three cases) and with BCM (one of
eight cases). There was no relevant adhesion to the
leptomeninges, while adhesion to the lesioned cortex
tended to be higher with DuraGen™ compared with BCM
and periosteum. However, macroscopic graft adhesion to
the cerebral tissue after 6 months post-implantation was
lower with DuraGen™ compared with periosteum and
BCM. Implant rejection was not observed in any group 6
months postoperatively. Histological analysis of the grafts
a n dg r a f ta d h e s i o n st ol e p t o m e n i n g e sa n dc o r t e xw a s
impossible due to their complete integration and mineral-
ization. Lymphocytic infiltration of the brain in the area of
the cortical lesion tended to be higher with DuraGen™ and
BCM compared with periosteum (no significant lympho-
cytic infiltration).
To the best of our knowledge, previous animal studies [7,
8, 17, 19] did not investigate adhesions between semisyn-
thetic collagen onlay grafts and lesioned cortex. Adhesions
between graft and cortex are of significance in clinical use,
since they might act as an epileptic focus. In the present
study, we observed no seizures in animals implanted with
semisynthetic grafts. Furthermore, adhesions are of clinical
relevance in the case of reoperation. In this case a strong
adhesion between dura mater or dural substitute and cortex
may complicate the surgical procedure and increase the risk
of neurological trauma. The present study provides no
definitive answer to the question of whether separation of
the brain and the dura mater in surgery is complicated by
the use of semisynthetic collagen onlay grafts. A relatively
high rate of fibrous reactions within the brain tissue at the
lesioned site with both onlay grafts (BCM, DuraGen™)
could be associated with the specifics of wound healing in
our model of growing pigs, since according to our
experience and a histopathological study [11] such changes
are rarely observed in humans. After 6 months, all cranial
defects were completely mineralized with ossification
extending far into the soft tissue scar, which, in our
opinion, is rarely observed in humans and may be
associated with our animal model.
Results of this study demonstrate high biocompatibility
for all dural substitutes, except for mild lymphocytic
infiltration of the brain parenchyma associated with the
onlay grafts, severe local or systemic toxicity, immunolog-
ical reactions were not observed clinically or histologically.
However, clinical relevance of slightly enhanced lympho-
cytic infiltration of brain parenchyma observed with onlay
grafts after 6 months remains to be determined.
In conclusion, the dura substitutes BCM and DuraGen™
(semisynthetic collagen matrices of bovine origin) appear to
be a promising alternative to duraplasty with endogenous
periosteum (Fig. 5), which is consistent with other studies
[11, 12, 16, 18]. Clinical studies are needed to show
whether BCM provides an alternative in clinical practice
and whether because of its bilayered structure provides a
BCM - periosteum 
DuraGenTM - periosteum 
BCM - DuraGenTM
of total rank difference 
-40    -20      0      20     40     60 
p = 0.0025 
p = 0.15 
p = 0.28 
Fig. 5 Statistical evaluation of the composite primary endpoint.
Paired difference of the composite score and 95% confidence intervals
between treatments from unpaired exact Wilcoxon test. Bars not
overlapping the vertical line at t=0 indicate significant effects
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Comment
This extensive animal model testing two artificial dural materials
against homograft in pigs, seeks to clarify if an ideal dural graft exists
that does not require the extensive dissection required for harvesting
of homograft material.
It would appear that one well-tried artificial substitute is quite
acceptable but there may be very slight advantages in a newer
material. Homograft has also very satisfactory properties.
Michael Powell
London, UK
2250 Acta Neurochir (2011) 153:2241–2250